National Institutes of Health Funding Enhances Biomedical Research on Health Disparities in Baltimore

Tuesday, 10 September 2024, 17:00

Baltimore receives vital NIH funding for specialized biomedical research targeting health disparities. Morgan State University's RCMI aims to address chronic conditions affecting minorities.
LivaRava_Medicine_Default.png
National Institutes of Health Funding Enhances Biomedical Research on Health Disparities in Baltimore

Increased Federal Funding for Biomedical Research

Morgan State University has received a $20 million federal grant to beef up its biomedical research center. The RCMI at Morgan focuses on chronic conditions (like cancer, diabetes, HIV, and COVID) that disproportionately affect minority groups, especially those living in urban Baltimore, announced the university today.

Research and Development Efforts

The $20.9 million grant from the National Institutes of Health (NIH) will fund five more years of research, including upgrading laboratory technology as needed and supporting career development for junior investigators. RCMI was launched in 2019 with a $14.2 million grant from NIH (specifically, its division for Minority Health and Health Disparities).

  • Investigation into chronic diseases like cardiovascular disease, asthma, cancer, and neurological disorders
  • Focus on prevention and treatment strategies

Paul B. Tchounwou, D.Sc., principal investigator and executive director of RCMI, commented on the new funding: Our team is dedicated to improving health outcomes in affected communities.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe